Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only.All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

Bioregulator_25MG

Cardiogen

Cardiogen is a synthetic short-chain peptide bioregulator originally studied for its sequence-specific activity within cardiac tissue models. Classified within the broader group of organ-specific peptide regulators, Cardiogen is utilized as a research reagent in laboratory investigations focused on gene expression, cellular signaling, and tissue-specific regulatory mechanisms associated with cardiac cells.*

Due to its defined amino acid sequence and reproducible synthesis, Cardiogen is commonly incorporated into experimental designs examining peptide–DNA interactions, transcriptional modulation, and peptide-mediated cellular regulation in cardiac-related research systems.*

  • Peptide Identity: Cardiogen
  • Peptide Class: Short-chain peptide bioregulator
  • Form: Lyophilized powder
  • Purity: ≥99% (HPLC verified)
  • Quantity: 20 mg per vial
  • Analytical Verification: HPLC and Mass Spectrometry (MS)
  • Manufacturing: Synthesized and quality-tested under controlled laboratory conditions
  • Designation: For Research Use Only (RUO)

$55.00

$52.25 each
$49.50 each

Products will arrive in a lyophilized (powder) form for maximum stability.

Free domestic shipping on orders over $300

Cardiogen

Scientific & Research Context

Cardiogen has been examined in preclinical and in vitro research as part of a class of peptides investigated for their ability to interact with cellular regulatory processes at the genetic and transcriptional level.* Published scientific literature on peptide bioregulators describes their sequence-dependent affinity for specific DNA regions and their role in modulating gene expression within differentiated tissues, including cardiac cell lines.*

Within research environments, Cardiogen has been studied in relation to:*

  • Cardiac cell signaling and regulatory pathway models*
  • Peptide–DNA and peptide–chromatin interaction studies*
  • Transcriptional regulation in differentiated tissue systems*
  • Structure–function relationships of organ-specific peptide regulators*

Its short length and tissue-associated sequence profile make Cardiogen a useful tool for mechanistic studies exploring how small peptides may influence cellular regulation at the molecular level.*

Quality & Analytical Assurance

Each batch of Cardiogen undergoes comprehensive analytical testing to confirm molecular identity, sequence accuracy, and purity using validated HPLC and MS methodologies. These quality controls ensure consistency, reliability, and reproducibility across research applications.

Storage & Handling

Cardiogen is supplied in lyophilized form to enhance stability during storage and transport. Store unopened vials in a cool, dry environment protected from light. Reconstitution and subsequent handling should follow established peptide research protocols to preserve integrity and experimental reliability.

For further information on proper storage techniques, click the button…

Storage Instructions

Referenced Scientific Literature
Provided for informational and educational purposes only

  • Khavinson VKh, Morozov VG. Peptides and ageing. Neuroendocrinology Letters, 2003; 24(6): 437–444.
  • Khavinson VKh, et al. Short peptides regulate gene expression. Bulletin of Experimental Biology and Medicine, 2010; 149(6): 714–717.
  • Khavinson VKh, Tendler SM, Vanyushin BF, Kasyanov VA, Ashapkin VV. Peptide regulation of gene expression: role of short peptides in epigenetic regulation of cell differentiation. Molecular Biology, 2012; 46(6): 781–789.
  • Khavinson VKh, Linkova NS. Peptides in regulation of cell differentiation and gene expression. Biogerontology, 2010; 11(3): 269–275.
  • Khavinson VKh, et al. Tissue-specific peptides regulate gene expression in cardiac cells. Bulletin of Experimental Biology and Medicine, 2007; 143(1): 80–83.
  • Anisimov VN, Khavinson VKh. Peptide bioregulators and their role in maintaining tissue homeostasis. Experimental Gerontology, 2010; 45(4): 254–259.
  • Ashapkin VV, et al. Short peptide regulation of DNA and chromatin structure. Molecular Biology Reports, 2014; 41(9): 6161–6168.
  • Khavinson VKh, et al. Organ-specific peptides and their role in molecular regulation of tissues. Advances in Gerontology, 2008; 21(1): 38–45.
  • Chalisova NI, et al. The effect of amino acids and cardiogen on the development of myocard tissue culture from young and old rats. Advances in Gerontology, 2009; 22(3): 409–413.
  • Levdik NV, Knyazkin IV. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats. Bulletin of Experimental Biology and Medicine, 2009; 148(3): 433–436.
  • Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA. CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell, 2005; 4(6): 291–298.
  • Kheifets OV, Polyakova VO, Kvetnoy IM. Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland during cell aging. Advances in Gerontology, 2010; 23(1): 68–70.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.